4 unknown. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 4 |
| Phase 2 | 3 | Unknown 3 |
Follow Relapse: new trials by email Literature Review of Relapse trials Research Report on Relapse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia Dual target CAR-T cell therapy - Dual-target CAR-T Cells, B ALL | Phase 1 / Phase 2 | Unknown | Shenzhen University General Hospital | 20 | 2020-10-20 | 2021-01-26 |
| CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia CD19 CAR-T cells, CD19 CAR-T cells with CRS suppression technology - Acute Lymphoblastic Leukemia, CD19 Positive | Phase 1 / Phase 2 | Unknown | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 40 | 2017-07-01 | 2024-05-28 |
| Chidamide Plus DCAG for Relapsed/Refractory AML Chidamide plus DCAG regimen - AML, Relapse | Phase 1 / Phase 2 | Unknown | Chinese PLA General Hospital | 100 | 2016-06-01 | 2018-02-14 |
| Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients DHAP, Brentuximab Vedotin, Autologous Peripheral Blood Stem Cell Transplantation - Hodgkin Lymphoma, Refractory | Phase 1 | Unknown | Marjolein Spiering | 72 | 2014-05-01 | 2018-03-13 |
Recurrence (4) · Burkitt Lymphoma (1) · Hodgkin Disease (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Disease Attributes (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Lymphoma (2) · DNA Virus Infections (1) · Epstein-Barr Virus Infections (1) · Hematologic Diseases (1) · Herpesviridae Infections (1)
Brentuximab Vedotin (1) · Cisplatin (1) · Dexamethasone (1) · N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (1)
Chinese PLA General Hospital (1) · Marjolein Spiering (1) · Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd (1) · Shenzhen University General Hospital (1)
China (3) · Denmark (1) · France (1) · Netherlands (1) · United Kingdom (1)
Anton Hagenbeek, PhD MD (1) · Li Yu, Dr (1) · Li Yu, MD. Ph.D (1) · Li-Xin Wang, MD. Ph.D. (1) · Marjolein Spiering, MSc (1) · Xiaowen Tang, PhD (1)
PMID 32273476, PMID 32873343, PMID 33235353, PMID 36105799, PMID 36241696, PMID 37722357